Clinical trials
Recruiting Phase 2 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Novo Nordisk A/S | 2 |
| Alnylam Pharmaceuticals | 1 |
| Biomea Fusion Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Corxel Pharmaceuticals | 1 |
| Estar Medical dba Medical Technologies, LTD | 1 |
| Gan and Lee Pharmaceuticals, USA | 1 |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 1 |
| Hanmi Pharmaceutical Company Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 34 |
| Obesity | 4 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Inflammation | 3 |
| Atherosclerosis | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Diabetic Nephropathies | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Overweight | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.